Literature DB >> 3374993

Quantification of cardiovascular instability in premature infants using spectral analysis of waveforms.

S Bignall1, P C Bailey, R P Rivers, T J Lissauer.   

Abstract

Spectral analysis was applied to blood pressure and cerebral blood flow velocity recordings in premature infants with respiratory distress in order to quantify respiration-induced cardiovascular variability. Aortic blood pressure was transduced via an umbilical arterial catheter and cerebral blood flow velocity measured in the anterior cerebral artery using a 10 MHz continuous wave Doppler velocimeter in 16 infants less than or equal to 32 wk gestational age. Spectral analysis of the resulting waveforms revealed heart rate and respiratory rate components whose relative amplitudes (heart rate/respiratory rate amplitude ratio) represent an index of that component of variability induced by respiratory events. The mean (heart rate/respiratory rate amplitude) ratio was 47.2 in spontaneously breathing infants and rose to 165.9 in infants who were ventilated during muscle paralysis (p = 0.0003). Cerebral blood flow velocity recordings showed R components in only 22 of 38 simultaneous recordings. This method can be used to quantify respiration-induced cardiovascular variability and its response to therapy, and may provide a means of identifying infants at risk from brain injury due to an inability to regulate cerebral blood flow.

Entities:  

Mesh:

Year:  1988        PMID: 3374993     DOI: 10.1203/00006450-198804000-00012

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  2 in total

1.  Cerebral blood flow velocity variability after cardiovascular support in premature babies.

Authors:  J M Rennie
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

2.  Factors associated with respiration induced variability in cerebral blood flow velocity.

Authors:  H Coughtrey; J M Rennie; D H Evans; T J Cole
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.